Russia Pharmaceuticals & Healthcare Report Q3 2014 from Monitor International
01 July 2014
Pharmaceutical companies will act to further localise pharmaceutical production in Russia over the medium term.
10 Health Tech Companies Changing The World
01 July 2014
Healthcare is such a bloated and bureaucratic industry that, at first glance, it might seem immune to disruption by innovators. But a new crop of tech entrepreneurs is trying to change that. Their products range from apps and social networks to robots and complex simulators. But they all share a common goal: to leverage new technology to fix an old industry.
First Patient Enrolled in ECOG-ACRIN Phase III Trial of Syndax’s Entinostat
30 June 2014
The ECOG-ACRIN Cancer Research Group and Syndax Pharmaceuticals Inc. announced today enrollment of the first patient in E2112, a randomized phase III clinical trial of Syndax’s histone deacetylase (HDAC) inhibitor, entinostat, for the treatment of patients with advanced breast cancer. The trial is evaluating whether the addition of entinostat to endocrine therapy (exemestane, a steroidal aromatase inhibitor) improves progression-free survival and/or overall survival in men and postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative advanced breast cancer who have progressed following treatment with a non-steroidal aromatase inhibitor.
Overcoming Clinical Challenges in BRIC Markets
20 June 2014
Rapidly changing markets raise potential for clinical trials in BRIC nations, despite challenges
10 June 2014
NovaDigm Therapeutics, a company developing innovative vaccines for fungal and bacterial infections, today announced that it has acquired the rights, in four separate transactions, to three well-studied Candida vaccine antigens, significantly bolstering the Company’s Candida vaccine pipeline.
FDA Issues Guidance on Expedited Programs for Serious Conditions
30 May 2014
FDA has finalized guidance on expedited programs for drugs and biologics to treat serious conditions. The guidance, released May 29, 2014, details four programs that the agency has designed to facilitate and expedite development and review of new drugs for the treatment of life-threatening conditions.
Report:Positive Outlook for Investment in Global Pharma and Biotech Industry
30 May 2014
New analysis from Frost & Sullivan’s Private Equity and Venture Capital Investment reveals the total number of private equity and venture capital (PEVC) deals in the pharmaceutical and biotechnology industry decreased from 1063 in 2010 to 480 in 2013. However, while the returns from the pharmaceutical and biotechnology industry have been dwindling, they are better compared to the performance of other industries, the report finds.
Improving the efficiency of health care will free up about 140-150 billion rubles
30 May 2014
Optimization of Health will release a significant amount of money , said the Minister of Health Veronika Skvortsova . At the current level of system performance by 2016 there may be some difficulties. However, if it significantly increase , the resource can be released about 140-150 billion rubles.
U.S.-Russia Innovation Corridor Selects Participants for Spring 2014
30 May 2014
Following a Competitive Selection Process, American Councils Announces Spring 2014 Residents in IT, biotechnology, and advanced manufacturing.
30 May 2014
The Intellectual Property & Science business of Thomson Reuters, the world leader in providing intelligent information to businesses and professionals, today announced the release of Overcoming Clinical Challenges in BRIC Markets, a report exploring the benefits and challenges of conducting clinical trials in the pharmaceutical markets of the BRIC nations: Brazil, Russia, India and China.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024